content
This website is intended for use by patients prescribed Somavert (pegvisomant) in the UK, and has been developed and funded by Pfizer Ltd.
This information is not intended to be a substitute for advice provided by a healthcare professional. For advice, please consult a healthcare professional.
Adverse event reporting statement can be found at the bottom of this page.
This information is not intended to be a substitute for advice provided by a healthcare professional. For advice, please consult a healthcare professional.
Adverse event reporting statement can be found at the bottom of this page.
image
eyebrow
headline
Welcome to your Somavert Support page
content
Here you can access services to assist you with your Somavert treatment.
buttons
disclaimer
placeholder_icon
placeholder_title
placeholder_body
headline
Use the buttons below to navigate to the service you require.
content
eyebrow
disclaimer
card_identifier
heading
Device Support
body
Click here to access videos and user guides to support you with your Somavert device.
cta
card_identifier
heading
Order Consumables
body
Click here to place an order for consumables to support you with your Somavert treatment.
cta
headline
content
Adverse Event Reporting
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Any suspected side effects may also be reported to Pfizer medical information on 01304 616161. By reporting side effects, you can help provide more information to the safety of this medicine.